BioAge Expands Metabolic Disease Pipeline with Nanobody-Based APJ Agonist from JiKang Therapeutics 05·06·2025
Genetic Engineering of VHH Antibodies Enables Precise Conjugation to Polysaccharides Using Thiol–Maleimide Chemistry 26·05·2025
Thymic Carcinoma Pipeline Shows Strong Momentum With 4+ Pharma Players Advancing Promising Therapeutics 22·05·2025
Radiopharm Theranostics Accelerates Phase 1 Clinical Trial of 177Lu-RAD204 Following Positive DSMC Review 13·05·2025